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General introduction 
 
Food compounds are composed of not only nutrients, but also of non-digestive 
compounds that affect the body. Polyphenols are one of these chemicals; they are 
secondary metabolites in plants and function as protective agents against stress. When 
consumed, dietary polyphenols help humans to prevent various diseases, including 
obesity [1]. One of the causes of obesity is excessive eating, which is generally 
regulated by the neuroendocrine system. It is possible that polyphenols affect this 
endocrine system and modify appetite. 
 
Anorexigenic gut hormones 
Postprandial energy metabolism is regulated not only by the brain, but also by 
gut organs. Its regulation is mediated by nervous and endocrine systems [2]. Key 
players of these systems are peptide hormones secreted from the gut epithelia in 
response to food compounds. At least 10 gut hormones were identified and revealed 
their contribution in digestion-related functions such as motility of the stomach and 
intestines, secretion of digestive enzymes, blood glucose homeostasis, and appetite 
control in the brain (Table 0.1). Part of the gut hormones reach the hypothalamus via 
afferent neurons that are innervated to the gastrointestinal tract, and accordingly 
modify food intake behavior [3]. Among these hormones, cholecystokinin (CCK), 
glucagon-like peptide (GLP)-1 and peptide tyrosine-tyrosine (PYY) have been shown 
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to be the primary satiety signals and act as anorexigenic hormones [4] (Figure 0.1). 
Dietary nutrients ingested in the gut are potent inducers of these gut hormones [4]. 
CCK is secreted from the proximal intestine such as the duodenum and jejunum in 
response to dietary carbohydrates, proteins and fats [4, 5]. CCK consists of a series of 
peptides which are cleaved from the common precursor composed of 115 amino acids. 
The one which is produced in the gut consists of 33 amino acids of 1 to 33 (CCK-33). 
CCK-33 is an amidated carboxy-terminal pentapeptide (Gly-Trp-Asp-Met-Phe-NH2
GLP-1 is released from the hind gut region such as the ileum and the colon in 
response to dietary carbohydrates, proteins, and fats [4, 7]. The secreted GLP-1 
reaches to the NST directly by blood stream or via signals in the vagal nerve. The 
active forms of GLP-1 produced in the gut are GLP-1 (7-37) and GLP-1 (7-36) amide, 
which is a C-terminal α-amidated form of GLP-1 (7-36). Secreted GLP-1 (7-36) 
amide is rapidly metabolized to GLP-1 (9-36) by dipeptidyl peptidase IV [8,9], which 
make a half life time of its efficacy in less than 2 minutes [9,10]. GLP-1 (9-36) 
comprises about 60% of circulating GLP-1 peptides in the blood and shown to no 
longer possess its bioactivity. 
) 
at their C-terminal, which confers the biological activity of CCK, and where the 
tyrosine residue occurs in sulfated form [6]. The secreted CCK is received by vagal 
afferent nerve which projects to the nucleus of the solitary tract (NST) in the brain 
stem. The neural network transmits the satiety input at NST to hypothalamus, where 
anorexigenic pathways are activated. 
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PYY is produced in the same cell which produces GLP-1 in the gut, and 
secreted in response to proteins and fats [4, 11]. PYY undergoes modification by 
cleaving the last 2 residues at N-terminus, tyrosine-proline residues, results to form 
PYY (3-36) [12]. PYY (1-36) amounts to about 60%, and PYY (3-36) does 40% of 
circulating PYY in the blood [13]. PYY (1-36) and PYY (3-36) cross the blood-brain 
barrier to be received at hypothalamus and related with weight control via feeding 
regulation [14, 15]. The PYY peptides selectively activate neuropeptide Y receptor 
(NPYR) isoforms. These are G protein coupled-receptors (GPCR) and consists 5 
isoforms [16]. PYY (3-36) is received by NPY2R and NPY5R, whereas PYY (1-36) 
activate NPY1R in addition to those 2 receptors [17]. Those 3 receptors were shown 
to be expressed in hypothalamus as well as the colon and the intestine. Especially, 
PYY (3-36) has been shown to induce anorexigenic effects through NPY2R and 
NPY5R [17, 18]. PYY (3-36) has been shown to have a longer duration of action than 
other anorexigenic peptides such as CCK and GLP-1 [3,4]. Together with other body 
states such as stomach distension and energy metabolism at the liver and adipocytes, 
anorexigenic gut hormones coordinate energy intake and expenditure through 
hypothalamus.  
 
Reception of food compounds 
The study of chemical reception of food compounds has revealed that some 
nutrients activate several kinds of GPCRs, including taste receptors, calcium-sensing 
receptor (CaSR), lysophosphatidic acid receptor 5 (LPAR5), G-protein coupled 
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receptor family C group 6 (GPRC6A), and free fatty acid receptors (FFARs) (Table 
0.2). Type 1 family of taste receptors, TAS1Rs, has been shown to be activated by 
sugars, amino acids and oligopeptides [19, 20]. CaSR and GPRC6A have also been 
shown to respond to amino acids [21, 22, 23]. LPAR5 has been shown to be activated 
by amino acids and protein hydrolysates [24]. FFARs respond to many kinds of free 
fatty acids [25, 26], i.e., FFAR1 and FFAR4, which are also called GPR40 and 
GPR120, have been known as a receptor for unsaturated medium and long chain free 
fatty acids [4,27]. FFAR2 and FFAR3, which are also called GPR43 and GPR41, 
have been shown to be activated by unsaturated short chain free fatty acids [4, 25, 26]. 
Some of these receptors have been shown to relate to gut hormone secretions. For 
example, TAS1R2 - TAS1R3 complex is activated by sugars, such as glucose, to 
release GLP-1 [28, 29]. On the other hand, gut hormones have been shown to be 
produced in the distinct cells located differently in the epithelia of the gut. Those 
enteroendocrine cells have been named as I, K, L, and M cells after their 
characteristics and locations (Table 0.1) [4]. As a receptor for amino acids, CaSR has 
been shown to be involved in both CCK secretion in I cells and GLP-1 secretion in L 
cells [4, 30]. GPRC6A receptor was also activated by amino acids, induced GLP-1 
secretion from GLUTag cell, an L-cell like model derived from mouse intestine [31]. 
Activation of LPAR5 by protein hydrolysate induces CCK transcription and secretion 
in STC-1 cell, a model enteroendocrine cell line derived from mouse small intestine 
[32]. For fat metabolites, FFAR1 and FFAR4 were revealed to mediate oleic acid 
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stimulation to induce CCK in I cells and PYY in L cells [21, 26]. Especially, FFAR4 
was revealed to be involved in the secretion of GLP-1 in vivo as well [33].  
Recently, it has been demonstrated that some non-nutrients act on the subfamily 
of bitter taste receptors in human, hTAS2Rs [34]. Among non-nutrients, polyphenols 
have been reported to activate these receptors, e.g., malvidin-3 glucoside activates 
hTAS2R7 [35, 36] and epigallocatechin-3-gallate (EGCg) activates hTAS2R14 and 
hTAS2R39 [36, 37]. On the other hand, some hTAS2Rs have been shown to act as 
triggers for gut hormone secretion. For example, activation of hTAS2R3, hTAS2R4, 
or hTAS2R46 by denatonium benzoate was shown to be involved in the GLP-1 
secretion [38] and activation of hTAS2R38 by phenylthiocarbamide was involved in 
the CCK secretion [39]. These examples demonstrate that not only nutrients but also 
non-nutrients possibly induce anorexigenic gut hormone secretion.  
 
Epigallocatechin-3-gallate 
Green and oolong teas have been reported to play a role of anti-obesity [40, 41]. 
The anti-obesity effect of teas was mainly attributed to catechins [30]. Catechins share 
a flavan-3-ol structure, which contains two benzene rings, A-rings and B-rings and a 
heterocyclic C-ring with a hydroxyl group on third carbon, and additionally contain 
another hydroxyl group on A-rings, B-rings or a galloyl group on C-ring. Most 
catechins have hydroxyl group at the C5 and C7 of the A-ring (Figure 0.2) [42, 43]. 
Among catechins, (-)-epigallocatechin-3-gallate (EGCg) is the most prevalent 
catechin in green tea and reported to have the anti-obesity activity [44]. EGCg is 
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accounting for 54%-59% of total green tea catechins, followed by EGC (9-12%), ECg 
(9-12%) and EC (5-7%) [45, 46]. The underlying mechanism of anti-obesity activity 
by EGCg was demonstrated in several ways: controlling adipocyte, inhibition of fat 
absorption, delaying glucose absorption, regulation of peroxisome proliferator-
activated receptors which mediates adipogenesis [40, 46, 47, 48]. In addition, it was 
shown that EGCg reduces adipogenesis through blocking of cell cycles [29]. 
Inhibitions of pancreatic lipase activity by EGCg reduced fat absorption from the gut 
[49]. EGCg was also shown to acutely reduce postprandial blood glucose levels via 
inhibition of α
 
-amylase activity [50, 51]. It was also reported that EGCg affects food 
intake reduction, which largely participate in reduction of body weight in lean and 
obesity patients [44]. However, it was not fully understood how EGCg leads reduction 
of food intake.  
This study has been performed to examine the hypothesis that polyphenols such 
as EGCg affect the secretion of anorexigenic gut hormones, CCK, GLP-1 or PYY, 
and cause reduction of food intake. In chapter 1, some polyphenols including EGCg 
found to induce CCK, GLP-1 and PYY secretion in vitro, and the effect of EGCg on 
secretion of anorexigenic hormones was confirmed ex vivo using murine intestines. In 
chapter 2, the molecular mechanisms of GLP-1 release by EGCg were investigated. 
To investigate a physiological effect of EGCg through anorexigenic gut hormones in 
vivo, food consumption was evaluated for 24 hours after EGCg administration in 
chapter 3.  
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Table 0.1. Gut hormones secreted in response to food compounds. 
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Figure 0.1. The schematic drawing of the function of anorexigenic gut hormones. 
Gut hormones are produced in the enteroendocrine cells located in the gut epithelia.  
Anorexic gut hormones, CCK, GLP-1, and PYY are secreted in response to the food 
compounds passing along the gut lumen. The hormones are transmitted to the brain 
where they affect the regulation of food intake.  
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Table 0.2. GPCRs which are activated by nutrients.  
 
 
* LPAR5; lysophosphatidic acid receptor 5 
# GPRC6A; G-protein coupled receptor family C group 6  
† GPR120; G protein-coupled receptor 119 
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Figure 0.2. The structure of catechins. 
(-) C (R1=H, R2=H, R3=OH) , (-) EC (R1=H, R2=OH, R3=H), (-) GC  (R1=OH, R2=H, 
R3=OH), (-) EGC (R1=OH, R2=OH, R3=OH) (-) Cg (R1=H, R2=H, R3=OG), (-) ECg 
(R1=H, R2=OG, R3=H),  (-) GCC  (R1=OH, R2=H, R3=OG), (-) EGCg (R1=OH, R2=OG, 
R3=H). OH, hydroxy group; OG, galloyl group.  
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Chapter 1 
 
Induction of secretion of anorexigenic gut hormones by 
polyphenols 
 
1.1 Introduction 
Gut hormones are produced and secreted from the enteroendocrine cells in 
response to food compounds. Enteroendocrine cells are distributed throughout the 
epithelial layer of gut [55]. There are more than 10 subtypes of enteroendocrine cells 
which release peptide hormones. Most of those cells secrete single hormone but some 
are able to secrete more than one hormone [4, 56]. In order to investigate the 
candidate inducers for these gut hormones, cultured cell lines provide useful tools. 
The Caco-2 cell line derived from a human colon cancer tissue is often used as an 
intestinal epithelial model for in vitro analysis of uptake of food compounds, whereas 
it is partially presents chromogranin A, which is widely expressed in enteroendocrine 
cells [57]. Therefore, it was worth evaluating to verify whether the Caco-2 cells can 
be used as a model for release of anorexigenic gut hormones such as CCK, GLP-1 and 
PYY. 
The functional food compounds apart from the nutrients are mostly secondly 
metabolites in various plants. Polyphenols are part of them and compose a large 
family. The family contains several thousand molecules, and among them, several 
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hundred are found in edible plants [58]. They are divided into flavonoids, 
phenylpropanoids and anthraquinones by the degree of polymerization of the phenol 
structure. Flavonoids are further divided into several groups such as flavonols, 
flavones, isoflavones, flavanones, and flavanols (Figure 1.1) [1]. In order to search 
new triggers for gut hormone release among polyphenols, at least one compound from 
each group were selected for the experiments of anorexigenic gut hormones.  
 
In this chapter, first, Caco-2 cell was evaluated if it secrets anorexigenic gut 
hormones in response to natural secretagogues, such as amino acids, fatty acids, and 
sugars. Then, polyphenols are applied to Caco-2 cells to search their activity on gut 
hormone secretion. To clarify if this effect of polyphenols on gut hormone release 
arise in animal tissues or not, an ex vivo analysis using murine intestines was 
performed. As a result, Caco-2 cell was shown to secrete CCK, GLP-1 and PYY in 
response to nutrients. Using Caco-2 cell, chlorogenic acid, EGCg, GCg, and ferulic 
acid were revealed to secret anorexigenic gut hormones. The fact that stereoisomers 
of EGCg share the functions on gut hormone release might provide electric properties 
of chemicals. Especially, EGCg was shown to induce all three hormones in vitro.  
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Figure 1.1. Chemical structure of polyphenols used in this study 
The names written in bold at upper position of structural drawings represent the groups, and 
those in the lower position represent the name of chemicals. 
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Figure 1.2. Chemical structures of catechins used in this study. 
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1.2 Materials and methods  
Oleic acid and resveratrol were purchased from Wako Pure Chemical Industries 
(Tokyo, Japan). Phenylalanine was from Nippon Rika (Tokyo, Japan). Quercetin was 
obtained from Sigma-Aldrich (St. Louis, MO, USA). Apigenin and emodin were from 
Tokyo Chemical Industry (Tokyo, Japan). Cyanidin chloride and hesperidin were 
from Extrasynthese (Genay, France). Ferulic acid and genistein were from LKT 
Laboratories (St. Paul, MN, USA). Dipeptidyl peptidase (DPP) IV inhibitor was from 
Calbiochem (San Diego, CA, USA). Palmitic acid, glutamine, glucose, sucrose, 
chlorogenic acid hemihydrates, (-)-epicatechin (EC), (-)-catechin (C), (-)-
epigallocatechin (EGC), (-)-gallocatechin (GC), (-)-epicatechin-3-gallate (ECg), (-)-
catechin-3-gallate (Cg), EGCg, (-)-gallocatechin-3-gallate (GCg), curcumin and 
sodium pyruvate solution were obtained from Nacalai Tesque (Kyoto, Japan). All 
other chemicals were of the highest grade commercially available. 
1.2.1 Chemicals.  
 
1.2.2 
All the procedures were performed at 37°C unless specifically described. Caco-
2 cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM, # D6429, 
Sigma-Aldrich) supplemented with 10% heat-inactivated fetal bovine serum (FBS) in 
a humidified atmosphere of 95% air-5% CO
Cell culture and treatment 
2. Cells were used from passage 54 to 58. 
For assays, cells were seeded into 24-well culture plate with 2 × 105 cells per well and 
incubated for 24 hours. Subsequently, the medium was changed to stimulant-
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containing assay buffer composed of phosphate buffered saline (PBS) containing 1 
mM pyruvate and 0.1 mg/ml DPP IV inhibitor. After incubation for 2 hours, assay 
buffers were collected and stored at -20°C until used. According to the stimulants’ 
solubility, the assay buffers were modified for each experiment. Oleic acid and 
palmitic acid were dissolved in dimethyl sulfoxide and diluted with assay buffer at 
1:1000. Each tested polyphenols was dissolved in solution composed by methanol and 
trifluoroacetic acid as 10:1, then diluted with assay buffer at 1:200. The 
concentrations of stimulants for the assay are as follows: glucose and sucrose, 100 
mM; glutamine, 25 mM; phenylalanine, 50 mM; oleic acid and palmitic acid, 1.5 mM; 
apigenin, genistein, hesperidin and quercetin, 100 μM; cyanidin, EC, C, EGC, GC, 
ECg, Cg, EGCg, GCg and resveratrol, 300 μM; chlorogenic acid and ferulic acid, 1 
mM; curcumin and emodin, 50 μM.  
 
1.2.3 RNA extraction and RT-PCR from Caco-2 cells
Total RNA was extracted using Sepasol (Nacalai Tesque) with manufactural 
instructions. Two micrograms of RNA were used for cDNA synthesis with ReverTra 
Ace (Toyobo, Tokyo, Japan). The sequences of primers (Invitrogen, Carlsbad, CA, 
USA) for analyzed genes are shown Table 1.1. The PCR program was 30 cycles of 
denaturation at 98°C for 10 seconds, annealing at 56-58°C for 30 seconds and 
extension at 68°C for 30 seconds by iCycler (Bio-Rad, Munich, Germany). The 
products were detected on an agarose gel by UV irradiation with ethidium bromide.  
.  
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Cell viability was determined using the CellTiter-Glo
1.2.4 Cell viability assay 
® luminescent cell 
viability assay (# G7570, Promega, Madison, WI, USA). Caco-2 cells (2×103) were 
seeded onto 384 well plates, incubated for 24 hours for adherence, and treated with 
stimulant for 2 hours. After rinse with PBS, CellTiter-Glo®
 
 reagent was added and 
mixed for 2 minutes on an orbital shaker to induce cell lysis, subsequently incubated 
at room temperature for 10 minutes. The luminescence was recorded by SH-9000 
microplate reader (Corona Electric Co., Ibaraki, Japan). Cell viability was calculated 
by each luminescent value normalized with that of the well treated with no stimulants, 
and present as percentiles. The assay was performed in triplicate for each stimulant.  
1.2.5 
This study was approved by the Institutional Animal Care and Use Committee 
(Permission number: 25-10-03) and carried out according to the Kobe University 
Animal Experimentation Regulations. Entire intestine of mice (ICR, male, 7 weeks, 
n=6) was excised and divided into duodenum, ileum and colon. Each piece of 
intestine was washed with Hanks’ balanced salt solution (HBSS, Nacalai Tesque) and 
cut into length of 0.5 cm. These pieces were turned inside out and immersed in 0.25 
ml of HBSS containing 0.1 mg/ml DPP IV inhibitor with or without 1 mM EGCg at 
37°C for 45 minutes. Subsequently, HBSS was collected and centrifuged at 4°C for 5 
minutes at 1000 g to remove debris. The supernatants were stored at -20°C until 
measured.  
Treatment of murine intestines 
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1.2.6 
Concentration of CCK, GLP-1 and PYY was measured by ELISA (# CEK-069-
04, # EK-028-11, and # EK-059-02, Phoenix Phamaceuticals. Burlingame, CA, USA) 
according to the manufacturer’s instructions with SH-9000 microplate reader. The 
primary antiserum for CCK cross reacts 100% with non-sulfated CCK (26–33) 
(human, rat, mouse), CCK (27-33), CCK-33 (porcine), big gastrin-1 (human), 
caerulein, gastrin-1 (human), 42.9% with CCK-33 (human), 12.6% with CCK (30–33), 
and 0% with pancreatic polypeptide (human) and vasoactive intestinal polypeptide 
(VIP; human, porcine, rat). The primary antiserum for GLP-1 cross reacts 100% with 
GLP-1 (7-36) (human, rat, mouse), GLP-1 (9-36) amide, GLP-1 (1-36) amide 
(human), 0.4% with GLP-1 (7-37) (human, rat, mouse), 0% with calcitonin gene 
related peptide (CGRP), exendin-4, glucagon (human, rat, mouse, porcine, bovine), 
glucose-dependent insulinotropic polypeptide, GLP-2 (human), insulin, secretin and 
VIP. The primary antiserum for PYY cross reacts 100% with PYY (human), PYY (3-
36) (human), 5% with PYY (rat, mouse, porcine), PYY (3-36) (rat, mouse, porcine), 0% 
with amylin amide  (human), glucagon (human), insulin (human), pancreatic 
polypeptide (human), porcine neuropeptide Y and substance P. Data are presented as 
mean ± SD of individual triplicate experiments. Data were presented as means ± SD 
of individual triplicate experiments. 
ELISA 
 
1.2.7 Statistical Analysis.  
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Dunnett’s test was performed to analyze the data of cultured cells. The data 
from the assay using murine intestines were analyzed by Student’s t-test. Provability 
(p) values below 0.05 were considered statistically significant. 
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Table 1.1. Sequence information for RT-PCR primers. 
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1.3 Results 
1.3.1 Endocrine characteristics of Caco-2 cells
The expression of genes encoding the anorexigenic gut hormones, CCK, GLP-1 
and PYY, was investigated. GLP-1 is dissociated from proglucagon by prohormone 
convertase 1 (PC1) during posttranslational processing [59]. RT-PCR analysis 
demonstrated that CCK, PC1, GCG (proglucagon) and PYY were expressed in Caco-2 
cells (Figure 1.3). Together with a report that has described CCK secretion from 
Caco-2 cells [39], these results suggest that Caco-2 cells potentially secrete GLP-1 
and PYY in addition to CCK.  
.  
 
1.3.2 Nutrients-dependent secretion of gut hormones from Caco-2 cells.  
In humans, CCK and GLP-1 are secreted in response to food intake of dietary 
carbohydrates, fats and proteins, whereas PYY secretion is induced by fats and 
proteins. The secretion of CCK, GLP-1 and PYY from Caco-2 cells was investigated 
by stimulating with the nutrients. Significant CCK secretion from Caco-2 cells was 
induced by all the tested compounds, except glutamine (Figure 1.4A). GLP-1 
secretion increased by all the compounds tested (Figure 1.4B). Only two compounds, 
glutamine and oleic acid, stimulated PYY secretion (F
 
igure 1.4C). The results indicate 
that the Caco-2 cell line was a feasible model for secretion of CCK, GLP-1 and PYY. 
1.3.3 Non-nutrients which induce secretion of gut hormones from Caco-2 cells. 
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To investigate whether polyphenols induce anorexigenic gut hormone secretion, 
Caco-2 cells were directly treated with polyphenols, followed by measurement of 
secreted hormones in the buffer. The cell viability assay was performed to confirm 
that the stimulants affect no damage at the each tested concentration (Figure 1.5). 
Among the polyphenols tested, EGCg significantly increased the secretion of CCK, 
GLP-1 and PYY from Caco-2 cells in 1.7, 1.8, and 2.0 fold, respectively (Figure 1.6). 
Ferulic acid increased CCK and GLP-1 secretion in 1.4 and 1.9 fold, respectively 
(Figure 1.6A and B). Chlorogenic acid increased CCK secretion in 1.3 fold (Figure 
1.6A). These result indicated that some polyphenols are able to induce CCK, GLP-1 
and PYY secretion. 
 
The induction of anorexigenic gut hormone release was compared among eight 
tea catechins listed in Figure 1.2. The catechins tested in this study are in pair of 
stereoisomers; C and EC, Cg and ECg, EGC and GC, and EGCg and GCg. 
Concentrations of catechins were determined by its solubility and cell viability. 
Catechins did not affect the cell viability of Caco-2 cells at 300 μM (Figure 1.7). 
When Caco-2 was stimulated, CCK secretion was induced by GC, EGCg and GCg in 
1.4, 2.2 and 2.1 fold, respectively (Figure 1.8A). EGCg and GCg increased GLP-1 
secretion in 2.0 and 1.7 fold and PYY secretion in 3.0 and 2.1 fold, respectively 
(Figure 1.8B and C). These results indicated that one pairs of stereoisomers, EGCg 
and GCg induced CCK, GLP-1 and PYY secretion.   
1.3.4 Gut hormones secretion from Caco-2 cells stimulated by catechins. 
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1.3.5 
To show whether the candidates proved to stimulate gut hormone secretion 
from Caco-2 cells also induce gut hormones in the tissue level, an ex vivo assay was 
performed using the duodenum, ileum and colon from mice. EGCg was selected as 
the test stimulant, because it induced the secretion of all three gut hormones from 
Caco-2 cells (Figure 1.6). Dissected murine intestines were treated for 45 minutes 
with 1 mM EGCg, a concentration that is in the range of green tea [58]. The results 
showed that significant CCK secretion induced by EGCg was observed in the 
duodenum (Figure 1.9A). A slight, but not significant induction of CCK secretion was 
observed in the ileum and colon (Figure 1.9A). GLP-1 secretion was to be secreted 
from the ileum (Figure 1.9B). These results supported the notion that EGCg is able to 
induce anorexigenic gut hormones in animals. 
Induction of anorexigenic gut hormone secretion from murine intestines by 
EGCg.  
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Figure 1.3. Expression of enteroendocrine genes in Caco-2 cells.  
Transcripts of GCG (lane 1), PC1 (lane 2), PYY (lane 3) and CCK (lane 4) were 
detected by RT-PCR. ACTB (lane 5) was used as a positive control. Lane M shows a 
100 bp DNA ladder. The expected sizes of the PCR products were 1: 758 bp, 2: 472 
bp, 3: 295 bp, 4: 462 bp, and 5: 470 bp. 
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Figure 1.4. Secretion of gut hormones from Caco-2 cells by stimulation of dietary 
nutrients.  
The secretion of CCK (A), GLP-1 (B), and PYY (C) from Caco-2 cells into the buffer was 
measured after incubation with nutrients for 2 hours. The stimulants’ concentrations of were: 
glucose, 100 mM; sucrose, 100 mM; glutamine, 25 mM; phenylalanine, 50 mM; oleic acid, 
1.5 mM and palmitic acid, 1.5 mM. A control value indicates the amount of the hormones in 
the assay buffer without the nutrients.*Statistical significance was determined by Dunnett's 
test at p < 0.05 vs. control (n=3). 
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Figure 1.5. Comparative cell viabilities exposed to polyphenols.  
Caco-2 cells were treated for 2 hours with polyphenols of indicated concentrations: quercetin, 
apigenin, hesperidin and genistein, 100 μM; EGCg, cyanidin and resveratrol, 300 μM; 
chlorogenic acid and ferulic acid, 1 mM; emodin and curcumin, 50 μM, and evaluated for the 
cell viability compare to the control, which treated without stimulants. No statistical 
significance was determined by Dunnett's test at p < 0.05 vs. control (n=3). 
. 
 
31 
 
Figure 1.6. Secretion of gut hormones from Caco-2 cells stimulated by polyphenols.  
The secretion of CCK (A), GLP-1 (B), and PYY (C) from Caco-2 cells into the buffer was 
measured 2 hours after incubation with the indicated polyphenols. The concentrations of each 
polyphenol was: quercetin, apigenin, hesperidin and genistein, 100 μM; EGCg, cyanidin and 
resveratrol, 300 μM; chlorogenic acid and ferulic acid, 1 mM; emodin and curcumin, 50 μM. 
Control indicates a sample stimulated only with assay buffer. *Statistical significance was 
determined by Dunnett's test at p < 0.05 vs. control (n=3). 
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Figure 1.7. Comparative cell viabilities exposed to eight catechins.  
Caco-2 cells were treated for 2 hours with 300 μM catechins. Cell viability was compared to 
the control, which treated without stimulants. No statistical significance was determined by 
Dunnett's test at p < 0.05 vs. control (n=3). 
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Figure 1.8. Secretion of gut hormones from Caco-2 cells stimulated by catechins.  
The secretion of CCK (A), GLP-1 (B), and PYY (C) from Caco-2 cells was measured 2 hours 
after incubating with catechins. The concentration of each catechins were 300 μM. Control 
indicates a sample stimulated only with assay buffer. *Statistical significance was determined 
by Dunnett's test at p < 0.05 vs. control (n=3). 
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Figure 1.9. Secretion of gut hormones from murine intestines in response to EGCg.  
The secretion of CCK (A) and GLP-1 (B) from inverted murine intestines was measured 45 
minutes after the treatment with (■) or without (□) 1 mM EGCg. *Statistical significance was 
determined by and Student’s t-test at p < 0.05 vs. each control (n=3).  
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1.4 Discussion 
Caco-2 cell line as a model of gut hormone release 
The Caco-2 cell line was induced to secrete CCK, GLP-1 and PYY in response 
to nutrients (Figure 1.4). The increase in CCK secretion by glucose, phenylalanine 
and oleic acid was equivalent to the experiments using humans [4, 60, 61]. Although 
CCK was shown to be secreted by proteins, the response to amino acids seems to be 
different among them, e.g., phenylalanine was shown to induce CCK secretion, 
whereas glutamine wasn’t [62]. STC-1 cell line was derived from murine intestinal 
cell and has been used for a model for I cells.  This cell was shown to induce secretion 
of CCK in response to free fatty acids and amino acids; palmitic acid and oleic acid as 
free fatty acids whereas phenylalanine as the most strong secretagogues among amino 
acids  [63, 64, 65]. Caco-2 cell in this study also showed response to free fatty acids 
and amino acids on CCK secretion. However, the intensity of responses toward each 
compounds seemed to differ between the cell models, STC-1 and Caco-2. It may due 
to the cellular characteristics including expression of genes related to the signaling 
cascades from receptors to hormone secretion. Further investigation of relation 
analysis between gene expression and response characteristics of hormone secretion 
may provide some strategy underlying this contradiction.  
The induction of GLP-1 by sucrose and glutamine was equivalent to that of 
direct induction in humans [66, 68] There is a cell line named NCI-H716 derived 
from a human colon tissue, proved to possess characteristics of enteroendocrinal L 
cells. This cell was shown to release GLP-1 in response to glucose, sucrose, oleic acid 
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and palmitic acid [28, 29]. A murine cell line named GLUTag cell has been also often 
used for GLP-1 release and was shown to respond to glutamine [69]. Caco-2 cell was 
considered to respond to as much stimulants as the other cell models do.   
The induction of PYY by oleic acid was equivalent to that of direct induction in 
humans [4, 61]. There is a report showing that administration of glutamine caused a 
trend of elevation of PYY level in blood [70], which may support the small induction 
of PYY by glutamine (Figure. 1.4C). There is no evidence on PYY secretion in 
response to palmitic acid in vivo, whereas an analysis using STC-1 cell line showed 
slight increase of PYY by palmitic acid [71]. Though STC-1 cell provides the only 
cell model to work on PYY secretion, there has been only small number of 
experiments performed. It is not clear why in vitro analysis for PYY has been poorly 
examined, but Caco-2 cell possibly provide a new tool to work with. Taken together, 
Caco-2 cell was shown to secrete three anorexigenic gut hormones in response to 
natural secretagogues in a feasible manner with in vivo experiments. Hence, Caco-2 
cell line is expected to provide useful model for finding the stimulants which induce 
the secretion of anorexigenic gut hormones. 
 
Non-nutrients as the inducer of anorexigenic gut hormones 
There are few reports showing that non-nutrients induce gut hormone secretion. 
The steroid glycoside, H.g.-12, from Hoodia gordonii has been shown to induce CCK 
secretion in HuTu-80 cells [72]. This compound has also been shown to be associated 
with loss of body weight [72]. Smeets et al. have found that capsaicin, the pungent 
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compound in red peppers, increased amounts of GLP-1 in human plasma [73]. 
Cinnamon, Cinnamomum, was found to have effect to increase GLP-1 levels in 
humans and mediate satiety [74]. Methyl syringate, a pungent ingredient in 
Kalopanax pictus, has been shown to significantly suppress food intake and delay 
gastric emptying via elevated plasma PYY levels in mice [75]. These reports support 
the idea that some non-nutrients stimulate the secretion of anorexigenic gut hormones 
including CCK, GLP-1 and PYY, causing appetite or food intake suppression. The 
present study demonstrated that EGCg stimulated the gut hormone secretion from 
cultured Caco-2 cells (Figure 1.6 and 1.8), and from murine duodenum and ileum 
(Figure 1.9). It has been reported that EGCg contributes to energy expenditure [62], 
that its consumption correlates with weight-loss led by reduction in food intake [44]. 
These physiological functions of EGCg may be associated with anorexigenic gut 
hormones, CCK, GLP-1 and PYY secretion. 
The present study also showed that ferulic acid induced the secretion of CCK 
and GLP-1 from Caco-2 cells (Figure 1.6A and B), and that chlorogenic acid induced 
CCK secretion (Figure 1.6A). Ferulic acid found in grains such as oats and rice has 
been shown to increase insulin secretion, delay intestinal glucose absorption, and 
inhibit gluconeogenesis [76]. Chlorogenic acid, which is a major polyphenol in coffee, 
reduces blood glucose level [77]. Besides the anorexigenic effect on the brain, CCK 
and GLP-1 are known to act on glucose homeostasis [75]. GLP-1 acts to stimulate 
glucose dependent insulin secretion, increased insulin sensitivity and inhibition of 
glucagon secretion [78]. CCK was known to induce glucagon release [79]. The 
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physiological effects of ferulic acid and chlorogenic acid on glucose homeostasis may 
be mediated by the stimulation of gut hormone secretion. 
 
Structure-activity relationship for gut hormone release 
Tea naturally contains a variety of catechins, which differ in the number of 
hydroxyl groups at the B-ring and the existence of a galloyl group at C-ring (Figure 
1.2) [80].  Catechin is the trans isomer, and EC is the cis isomer. catechin and EC are 
converted to hydroxylation forms as GC and EGC, respectively. They can acylate 
with gallic acid to form gallate forms such as Cg, ECg, GCg and EGCg [81]. It has 
been reported that physiological roles of catechins are dependent on their structure [82, 
83]. For example, ability to scavenge free radicals among catechins found relate with 
the hydroxyl groups on the B-ring and a galloyl group bound to the position 3 of the 
C-ring [83]. A pair of structural isomers of EGCg and GCg showed the most 
resembled activity each other, revealed strong induction of CCK, GLP-1, and PYY 
(Figure 1.8). They share a pyrogallol structure possessing three hydroxyl groups on 
the B-ring and galloyl group at the position 3 of the C-ring, thus these characteristics 
may provide stronger reactivity compare to other catechins used in this study. When 
the effect of green tea catechins, EC, EGC, ECg and EGCg was compared on Sprague 
Dawley rats, EGCg showed significant reduction of food intake, whereas other 3 
catechins didn’t [44]. If the structure-activity relationship would be revealed, it may 
offer the more active derivatives.  In chapter 1, Caco-2 cell line was shown to be an in 
vitro model for CCK, GLP-1 and PYY secretion. Among several polyphenols, 
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chrologenic acid, EGCg, feluric acid, and GCg were revealed to induce one or several 
anorexigenic gut hormones secretion. EGCg induced the secretion of three 
anorexigenic gut hormones, CCK, GLP-1 and PYY in vitro and EGCg was shown to 
secrete CCK from the duodenum, and GLP-1 from the ileum in ex vivo experiments 
using murine intestines. Since a stereoisomer of EGCg, GCg showed similar activity 
on anorexigenic gut hormone release, the stimulation mechanism of polyphenol might 
relate to their electronic properties than steric characteristics. These findings suggest 
that polyphenols present appetite control by induction of secretion of anorexigenic gut 
hormones.  
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Chapter 2 
Molecular mechanisms underlying GLP-1 secretion induced 
by (-) epigallocatechin-3-gallate
 
  
2.1 Introduction 
The series of studies on molecular mechanisms of gut hormone secretion in 
enteroendocrine cells revealed the signaling cascades from receiving the stimulus 
until releasing hormones. Similar to other peptide hormones such as insulin, gut 
hormones are also secreted via exocytosis of secretory granules. The trigger of 
degranulation is often demonstrated as a topical increase of intracellular Ca2+ 
concentration ([Ca2+]i) [84, 85], which caused by extracellular Ca2+ entry and/or 
release of Ca2+from intracellular stores. Using these model cells such as GLUTag 
cells, it is shown that glucose and amino acids, such as glutamines, trigger 
depolarization resulting in Ca2+ entry and initiation of GLP-1 secretion [69, 86]. 
Medium chain fatty acids are shown to trigger release of Ca2+ from intracellular stores 
and GLP-1 secretion from the STC-1 cell line [87]. Other secretagogues for GLP-1, 
protein hydrolysate and fatty acids also showed elevation of intracellular calcium 
concentration in NCI-H716 [29, 88]. The elevation of [Ca2+]i  in enteroendocrine cells 
by stimulation will provide a strong evidence for hormone release. Figure 2.1 shows 
inner cellular molecular mechanisms of CCK, GLP-1 and PYY secretions in 
enteroendocrine cells. 
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The binding of ligands to transmembrane receptors generally induce structural 
changes which arise the inner cellular signaling transduction [89]. After being 
stimulated, the receptors need to be recovered to non-active form. One way of this 
recovery is degradation of the receptor-ligand complex in the cells. The endocytosis 
of those receptors triggers up-regulation of transcription of receptors [90, 91]. This 
phenomenon is observed in reception of food compounds as well. For example, a 
pungent phytochemical, capsaicin, is known to activate a member of transient 
receptor potential channel (TRP) subfamily V, TRPV1, and up-regulate mRNA and 
protein levels of TRPV1 itself after reception of capsaicin [92]. Evaluating the 
expression of receptors would provide a basis to screening candidates which bind to 
the ligands. 
The induction of gut hormone release by EGCg is also expected to involve an 
increase of inner cellular Ca2+ concentration. Recently, two families of receptors were 
shown to be activated by EGCg and induce Ca2+ influx. A nociceptive receptor, 
TRPA1 is an ankyrin repeat containing member of the TRP channels, and transfers 
extracellular Ca2+ into cytosol in response to cinnamaldehyde and allyl isothiocyanate 
(AITC) [93]. Identically, EGCg was shown to activate TRPA1 and triggers Ca2+ 
influx [94]. On the other hand, human bitter taste receptor family is another receptor 
family which also be activated by EGCg. Two molecules, hTAS2R14 and hTAS2R39, 
were shown to be activated by EGCg and transmit the signal to increase Ca2+ [36, 37]. 
Thus, hTAS2R14, hTAS2R39, and TRPA1 are considered to be the strong candidate 
for the mediator of gut hormone release by EGCg in enteroendocrine cells. On the 
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other hand, a non-integrin cell surface receptor, a 67 kDa laminin receptor (67LR) is 
famous to mediate EGCg stimulation in tumor cells and induces various functions, 
such as inhibition of cell growth, induction of apotosis, downregulation of 
inflammatory mediators, and inhibition of histamine release [47, 49, 95]. Especially 
the inhibitory function against histamine release is caused by reconstruction of 
cytoskeletal organization mediated by a phosphorylation signal under control of 
eukaryotic translation elongation factor 1A (eEF1a) [96, 97]. Since the signal 
downstream of 67LR-eEF1a seems to work another way to induction of degranulation, 
this reaction should have been investigated.  
Caco-2 cell is feasible and useful especially to search stimulants for 
anorexigenic gut hormone in human, but this cell possesses an experimental difficulty 
in chemical loading [98]. This characteristic might be a disadvantage to research on 
inner cellular signaling. As described in chapter 1, NCI-H716 cell line derived from 
human colon cell possesses enteroendocrine characteristics of L cells [29]. This cell 
line is often used for analysis on GLP-1 release. Even, this cell line has evidence to 
demonstrate Ca2+
In chapter 1, EGCg was shown to induce anorexigenic gut hormones. In 
Chapter 2, it is examined if signals from receptors of EGCg cause an increase in 
intracellular Ca
 increase in response to protein hydrolysates [99]. Thus, NCI-H716 
cell was considered to be a good alternative model cell to investigate signaling 
pathway of GLP-1 release. 
2+ level, and thereby induce degranulation which allows release of the 
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peptide hormones. Thus, inner cellular Ca2+
  
 levels were evaluated after stimulation by 
EGCg using NCI-H716 cells.  
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Figure 2.1 The Ca2+
 
 dependent signaling pathways related to gut hormone secretion in 
the enteroendocrine cells.  
Schematic drawings show the Ca2+
  
 dependent signaling pathways underling nutrients induced 
gut hormone secretions in enteroendocrine cells. Left: Known pairs of secretagogues and 
receptors for CCK secretion demonstrated in I cells or STC-1 cells. The receptor responsible 
for glucose in CCK secretion is still missing. Right: Known pairs of secretagogues and 
receptors for GLP-1 and PYY secretion demonstrated in L cells or L cell-like cultured cells. 
The activation of FFAR2 by SCFA shares both GLP-1 and PYY secretion. The receptor 
responsible for amino acids in GLP-1 secretion is still missing. GPRC6A, G-protein coupled 
receptor family C group 6; GPR119, G protein-coupled receptor 119; LPAR5, 
lysophosphatidic acid receptor 5; SCFA, short-chain fatty acids; LCFA, long-chain fatty 
acids. 
 
45 
 
2.2 Materials and methods 
2.2.1 
Caco-2 cells were maintained by the same way as Chapter 1. NCI-H716 cells 
were cultivated in RPMI 1640 medium (Wako Pure Chemical Industries) 
supplemented with 5% FBS in a humidified atmosphere of 95% air-5% CO
Cell culture 
2
 
. Before 
assays, the cells were seeded on cell matrix (#637-00653, Nitta Gelatin, Osaka, Japan) 
and cultured in DMEM with 10% FBS for 48 hours for differentiation. NCI-H716 
cells were from passage 7 to 11.   
2.2.2 RNA extracttion and quantitative PCR  
Caco-2 cells are incubated at 37°C for 2 hours after adding phenylalanine, oleic 
acid, and EGCg of final concentrations of 50 mM, 1.5 mM and 300 μM, respectively. 
Subsequently, total RNA of Caco-2 cells was extracted by using Sepasol (Nacalai 
tesque) with manufactural instructions, and then 1 μg of RNA was used for cDNA 
synthesis with ReverTra Ace (Toyobo). The sequences of primers (Invitrogen) for 
analyzed genes are shown in Table 2.1. The program for real time qPCRs was 50 
cycles of denaturation at 95°C for 10 seconds, annealing at 55°C for 20 seconds and 
extension at 72°C for 20 seconds. The Ct values bigger than 35 were considered as 
too low expression to evaluate. Gene expression ratio was normalized to average of Ct 
values on B2M, GAPDH, HPRT1 and ACTB as a housekeeping gene. 
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2.2.3 GLP-1 secretion stimulated by EGCg
The inhibitors were prepared as follows; 10 mg/ml solution of anti-67LR 
antibody (#MS-259-PABX, Thermo Fisher Scientific, Waltham, MA, USA), 20 mM 
DMSO solution of AP18 (Enzo Life Science, Farmingdale, NY, USA), 10 mM 
DMSO solution of U73122 (Cayman Chemical, Ann Arbor, MI, USA). Caco-2 cells 
were seeded into 24-well culture plate with 2×10
 with pretreatment of inhibitors of EGCg 
candidate receptors 
5
 
 cells per well and incubated at 
37°C for 24 hours. The medium was changed to each inhibitor solution diluted with 
PBS containing 1 mM pyruvate at 1:1000, and incubated for 30 minutes. Then buffer 
was changed to 300 μM EGCg containing assay buffer containing 0.1 mg/ml DPP IV 
inhibitor. After incubation for 2 hours, assay buffers were collected and stored at -
20°C until used. Concentration of GLP-1 was measured as described in Chapter 1. 
Data are presented as means ± SD obtained from triplicate wells. 
2.2.4 GLP-1 secretion from Caco-2 cell and NCI-H716 cells stimulated by EGCg  
Caco-2 cells were seeded into 24-well culture plate with 2×105 cells per well 
and incubated at 37°C for 24 hours. NCI-H716 cells were seeded into 24-well culture 
plate precoated with cell matrix (Nitta Gelatin) with 2×105 cells per well and 
incubated at 37°C for 2 days. Subsequently, the medium was changed to 1 mM EGCg 
containing assay buffer composed of PBS containing 1 mM pyruvate and 0.1 mg/ml 
DPP IV inhibitor. After incubation for 45 minutes, assay buffers were collected and 
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stored at -20°C until used. Concentration of GLP-1 was measured as described above. 
Data are presented as means ± SD of triplicate experiments.  
 
2.2.5 C
Caco-2 cells and differentiated NCI-H716 cells were prepared in 96-well 
culture plate with 4×10
alcium imaging 
4
 
 cells per well density. The medium was removed, and the 
cells were incubated with 100 µl of 4 μM Fluo-8 AM (AAT Bioquest, Sunnyvale, CA, 
USA) in PBS for 1 hour. The cells were washed twice with PBS and placed at 
inverted microscope (BIOREVO, BZ 9000; Keyence, Osaka, Japan). After adding 
ionomycin (Nacalai tesque) and EGCg of final concentrations 50 μM and 300 μM 
respectively, fluorescent images were recorded by each 8 seconds for 2 minutes. The 
fluorescent intensity calculated from each image was analyzed to evaluate inner 
cellular calcium concentrations.  
2.2.6 
Dunnett’s test was applied to compare GLP-1 secretion among samples treated 
with EGCg receptor related inhibitors. Student’s t-test was applied for qPCR analysis 
and GLP-1 secretion analysis between stimulated by EGCg and buffer. Provability 
values below 0.05 were considered statistically significant. 
Statistical Analysis 
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Table 2.1. Sequence information for RT-PCR primers. 
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2.3 Results 
2.3.1 Investigation of the up-stream pathway of GLP-1 secretion by EGCg in Caco-
2 cells 
To examine the involvements of EGCg receptors in induction of GLP-1 
secretion, amount of GLP-1 released with selected antibody and inhibitors was 
measured from Caco-2 cells. Anti-67LR antibody  (#MS-259-PABX) is used as a 
neutralizing antibody against 67LR activation. AP18 is an antagonist against TRPA1. 
The other inhibitor, U73122 was selected because it blocks the downstream signaling 
of G-proteins by inhibiting the activity of β subtype of phospholipase C enzymes 
(PLCβ), which regulate the downstream signaling of TAS1Rs and TAS2Rs. The 
addition of these inhibitors hardly affected GLP-1 secretion from Caco-2 cells 
compared to stimulation of EGCg alone (Figure 2.2). It was not clear if this result 
demonstrated the incompetency on GLP-1 release by EGCg, because the intracellular 
signaling was not evaluated.  
To see the effect of EGCg on candidate receptors directly, the expression levels 
of receptors after stimulation was evaluated. First, the response of the receptors 
involved in the reception of the natural secretagogues were examined. The qPCR was 
performed to compare expressing levels of CASR in response to phenylalanine, or 
FFAR1 and FFAR4 in response to oleic acids. Stimulation with phenylalanine 
increased CASR expression in 2.1 fold to control. Oleic acid increased 3.8 fold 
expression of FFAR4, whereas the expression of FFAR1 was not detected. In addition, 
the same method was applied to evaluate the expression of candidate EGCg receptors. 
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After stimulation of EGCg, expression of TAS2R39 increased 7.2 fold, but those of 
T2R14, 67LR and TRPA1 were not changed (Table 2.2). This result indicated that 
hTAS2R39 might be related to recognition of EGCg in Caco-2 cells.  
 
2.3.2 Changes in intracellular calcium concentration under stimulation of EGCg 
Gut hormone secretion often requires increase in intracellular Ca2+ 
concentration.  Therefore, the effect of EGCg on intracellular Ca2+ concentration was 
investigated. At first, Caco-2 cell was tried to be loaded with the calcium indicator, 
Fluo-8. However, this method applied with Caco-2 cells, an addition of an ionophore, 
ionomycin, did not affect inner cellular calcium increase (Figure 2.3). The other 
human endocrine cell line, a NCI-H716, was then analyzed for its ability of 
responding to EGCg. As shown in Figure 2.4, NCI-H716 was confirmed to induce 
GLP-1 by stimulation of 300 μM EGCg as similar level as Caco-2 does. The loading 
of Fluo-8 showed detection of calcium influx by ionomycin (Figure 2.4 B), which 
confirm the adaptation to Ca2+ imaging analysis. When NCI-H716 cells were 
stimulated by 300 μM of EGCg, the increase of intracellular Ca2+ was observed from 
8-16 seconds. (Figure 2.4C). These results offer the possibility that increased Ca2+ by 
EGCg is one of the pathway of secretion GLP-1. 
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Figure 2.2. Effect of inhibitors for EGCg receptor pathway on GLP-1 secretions from 
Caco-2 cells stimulated by EGCg.  
The secretion of GLP-1 from Caco-2 in the buffer was measured 2 hours after incubating 
with 300 μM EGCg, with the preincubation with anti-67LR antibody, TRPA1 antagonist 
(AP18) and PLC inhibitor (U73122). Control indicates a sample stimulated only with assay 
buffer. *Statistical significance was determined by Dunnett's test at p < 0.05 vs. control 
(n=3).  
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Table 2.2. mRNA expression values of binding receptors after stimulated by 
ligands in Caco-2 cells. 
 
Real time qPCR was performed to compare gene expressions after addition of stimulants. (A) 
Expression of CaSR in response to phenylalanine. (B) Expression of FFAR4 and FFAR1 in 
response to oleic acid. (C) Expression of candidate receptors after stimulation by EGCg. The 
stimulants were; 50 mM phenylalanine, 1.5 mM oleic acid, and 300 μM EGCg. The level of 
expression was normalized to average of Ct values of house keeping genes; B2M, GAPDH, 
HPRT1 and ACTB. Statistical significance determined by and Student’s t-test at p < 0.05 to 
each control (n=3). N.D. ;couldn’t evaluate because of too low expression. 
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Figure 2.3. Calcium imaging on Caco-2 cells response to EGCg.  
(A) Increase in intracellular Ca2+
  
 concentrations after adding ionomycin (left) or PBS (right) 
on Caco-2 cells are introduced with Fluo-8. The images were obtained immediately after 
adding samples (0 second) and after 24 seconds by a fluorescence microscope. (B) The traces 
of fluorescent intensity in individual cells by 8 seconds intervals. Scale bar ; 50 μm. 
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Figure 2.4.The response of NCI-H716 cells stimulated by EGCg.  
(A) Alteration of GLP-1 secretions from Caco-2 cells (left) and NCI-H716 cells (right) 
simulated by 1 mM EGCg was evaluated. *Statistical significance was determined by and 
Student’s t-test at p < 0.05 to each control (n=3). (B) Increase in intracellular Ca2+
  
 
concentrations after adding ionomycin or EGCg on NCI-H716 cells introduced with Fluo-8 
was detected. The images were obtained immediately after adding samples (0 second) and 
after 24 seconds by a fluorescence microscope. (C) The traces of fluorescent intensity in 
individual cells by 8 seconds intervals. Scale bar ; 50 μm. 
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2.4 Discussion 
Differentiation in usage between Caco-2 and NCI-H716 
In this chapter, other human cell line named NCI-H716 was also used to study 
gut hormone secretion in response to EGCg. NCI-H716 was derived from colon and 
shown to have L-cell like characteristics, thus used as an in vitro model for GLP-1 
and PYY secretion. As described in chapter 1, the response to nutrients in GLP-1 
release is similar between NCI-H716 and Caco-2 [28, 29]. In addition, the increase of 
GLP-1 secretion in response to EGCg was also similar (Figure 2.4A). Compare to the 
number of researches performed with NCI-H716 on GLP-1, there are no PYY 
secretion by nutrients’ induction from NCI-H716. The transcriptional characteristics 
showed NCI-H716 expressed variety of hTAS2Rs including hTAS2R14 and 
hTAS2R39 as well as gustducin, which works as a binding G-protein to transmit the 
signals from T2Rs [100, 101], whereas Caco-2 was confirmed to express gustducin 
and PLCβ2, which is an effector enzyme underlying TAS1Rs and TAS2Rs (data not 
shown). Since it is known that taste receptors and the down signaling molecules were 
expressed in enteroendocrine cells in vivo, both NCI-H716 and Caco-2 are considered 
to share the original characteristics of enteroendocrine cells. Regarding to the 
response to nutrients and the transcriptional characteristics, Caco-2 cell and NCI-
H716 cell are comparable models [28, 29]. However, loading a calcium indicator into 
Caco-2 cell was impossible, likewise other techniques such as transfections of nucleic 
acids [102, 103]. Caco-2 might relatively resistant to be introduced compounds, may 
due to the tight connection between cells. Ionomycin is a chemical which act as 
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ionophoric Ca2+
Possibility of hTAS2R39 being as the EGCg receptor in GLP-1 secretion 
 transport traverse membrane. The addition of ionomycin clearly 
showed that NCI-H716, but not Caco-2, succeeded to provide the experimental basis 
for calcium imaging. In this sense, NCI-H716 may provide a better tool to investigate 
inner cellar mechanisms. However, it is not negligible that Caco-2 might be suitable 
to examine PYY secretion, since NCI-H716 has not been examined.      
To clarify the molecular mechanism underling the EGCg induction on GLP-1  
secretion, three experiments were performed considering candidate four receptors; 
67LR, hTAS2R14, hTAS2R39, and TRPA1. The 67LR neutralizing antibody didn’t 
affect GLP-1 secretion by EGCg nor TRPA1 antagonist didn’t affect GLP-1 secretion 
by EGCg, nor U73122 inhibit the downstream of GPCR, such as hTAS2Rs. The gene 
expression analysis showed only hTAS2R39 was up-regulated, which is similar to 
those of CASR in response to phenylalanine and FFAR4 in response to oleic acid. 
When changes of [Ca2+]i was detected after stimulating EGCg by fluorescent 
indicator, Fluo-8, NCI-H716 cells showed increase of fluorescence, which 
demonstrate that Ca2+
An up-regulation of transcripts of hTAS39 by EGCg stimulation would provide 
verification for its involvement of EGCg-dependent inner cellular signaling. The 
downstream signaling was considered to be G-protein mediated pathway (Figure 2.1). 
The signal downstream of GPCRs depends on the coupling G-proteins. It is well 
known that TAS2Rs activate PLC resulting in elevation of [Ca
 influx arose under stimulation of EGCg.  
2+]I in mainly taste 
receptor cells. On the other hand, there seems to be some other pathways to initiate 
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GLP-1 release in enteroendocrine cells. An elevation of cyclic AMP (cAMP) triggers 
GLP-1 release via [Ca2+]i elevation in GLUTag cells [104] (Figure 2.5 A left). 
Phosphodiesterase (PDE) regulates the cellular levels of cAMP downstream of 
glucose [105]. A stimulation of denatonium benzoate, which activate TAS2Rs, 
induced GLP-1 secretion via PDE activation, independent to [Ca2+]i in NCI-H716 
cells [100] (Figure 2.5A right). The candidate receptor for EGCg in enteroendocrine 
cells estimated as hTAS2R39, which shares the expression profile with both TAS1Rs 
and TAS2Rs. It is possible that the stimulation of EGCg might mediate its signal via 
PLC independent pathway (Figure 2.5B). The evaluation of intracellular cAMP levels 
would provide more strong evidence for possible pathways for GLP-1 release under 
TAS2Rs. Another reason for the conflicting result with PLC activation would be 
caused by unsuccessful permeation of U73122 into Caco-2 cells. The proof would be 
provided by the direct evaluation of activity of PLC such as measuring IP3 and 
diacylglycerol. As shown in Figure 2.4, [Ca2+]i was elevated by stimulation of EGCg. 
The requirement of [Ca2+]i for GLP-1 secretion by EGCg will be confirmed by 
measuring GLP-1 under depleting extracellular Ca2+ or addition of blocker of voltage 
dependent calcium channels. Altogether, the mechanism of EGCg stimulation on 
GLP-1 release in Caco-2 cells was shown to possibly involve hTAS2R39 and 
subsequent [Ca2+]i elevation. It is shown that EGCg induced an elevation of [Ca2+]i in 
NCI-H716 cells, which supports the idea that GLP-1 release was occurred via 
elevation of [Ca2+]i in response to EGCg. The candidate receptor for EGCg in 
intestinal cells is estimated as hTAS2R39 from gene expression analysis using Caco-2. 
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The conflicting result showing the non-effectiveness of the inhibitor for PLC on the 
secretion of GLP-1 by EGCg stimulation, might due to a concurrent contribution to 
degranulation, such as cAMP dependent pathway (Figure 2.5B). Through the analysis 
in this chapter, a molecular mechanism to secrete GLP-1 stimulated by EGCg is 
partially revealed. The expected signaling is activation of TAS2R followed by 
elevation of [Ca2+]i
 
 and subsequent exocytosis of secretion granules. Further 
experiments such as gene knock down analysis by RNA interference would be needed 
to confirm the whole pathway. 
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Figure 2.5 Intracellular signaling pathways underling GLP-1 secretion of taste 
receptors   
Schematic drawings of the intracellular signaling pathways for GLP-1 secretion in cultured 
cells stimulated by denatonium benzoate, glucose or glutamine, and EGCg. (A) Left: The 
signaling cascades inducing elevation of [Ca2+]i stimulated by glucose or glutamine. The 
molecules framed in red indicate the factors whose activity is confirmed in murine GLUTag 
cells [79]. Right: GLP-1 is released through both Ca2+ dependent and independent pathways 
by stimulation of denatonium benzoate. The molecules framed in red indicate the factors 
whose activity is confirmed in human NCI-H716 cells [22]. (B) The summary of the result 
obtained in this study. The involvement of hTAS2R39 was expected by PCR analysis in 
human Caco-2 cells, and elevation of [Ca2+]i was demonstrated in human NCI-H716 cells. 
The involvement of PLC was disproven in Caco-2 cells. AC, adenylcyclase; cAMP, cyclic 
AMP; DAG, diacylglycerol; PDE, phosphodiesterase; PIP2
 
, phosphatidylinositol 4,5-
diphosphate; PKA, protein kinase A; PKC, protein kinase C; PLC, phospholipase C; VDCC, 
voltage-dependent calcium channel. 
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 Chapter 3 
Effect of (-) epigallocatechin-3-gallate
 
 on the regulation of 
food intake 
3.1 Introduction 
The control of feeding and energy expenditure is a homeostatic process. This 
process is taken place in several regions of brain; the arcuate nucleus (ARC), and the 
dorsal vagal complex in the hypothalamus [90]. The anorexigenic gut hormones are 
transmitted via blood circulation or vagus nerves to brain and affect hypothalamus.   
CCK and PYY signals reach hypothalamus mostly via a neural pathway to the 
brainstem [106, 107]. GLP-1 receptors are found in large part of brain regions 
involving ARC and the brainstem, in addition to various peripheral tissues such as 
vagus nerves [108]. The fact that both central and peripheral administration of GLP-1 
to rats inhibits food intake means that this hormone effect directly on brain and also 
from periphery through vagus nerves [109]. Peripheral administration of CCK in 
rodents and humans led to a decrease in meals size [110, 111]. Intravenous 
administration of an antagonist of CCK receptor in humans decreases satiety and 
increase hunger and meals size [112]. Also, central and peripheral injection of PYY in 
rodents results in food intake reduction [113]. It seems that PYY is more effective in 
obese condition; Intravenous administration of PYY in obese people resulted in a 
comparable decreasing in food intake when compared with normal controls [114]. It 
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is also demonstrated that the intraperitoneal administration of CCK, GLP-1 and PYY 
diminish the food intake [90, 91, 115].  
It is known that non-nutritional secretagogue for gut hormones affect regulation 
of food intake, e. g., cinnamaldehyde and methyl syringate suppress food intake via 
anorexigenic gut hormone [74]. Cinnamaldehyde and methyl syringate induced PYY 
secretion in mice [75]. Cinnamaldehyde and methyl syringate administered orally at a 
dose of 10 mg/kg after fasting induced reduce of food intake in mice [74].  
According to chapter 1, showing that EGCg induces CCK, GLP-1 and PYY 
secretion from cultured intestinal cells. Furthermore, EGCg induces CCK and GLP-1 
secretion in dissociated murine intestines. Because of these results, the physiological 
effect of EGCg was investigated by evaluating meal size during each 2 hours for 
successive 24 hours in mice.  
 
  
 
62 
 
3.2 Materials and methods 
The study was approved by the Institutional Animal Care and Use Committee 
(Permission number: 25-10-03) and carried out according to the Kobe University 
Animal Experimentation Regulations. Male ICR mice (9 weeks old) weighing 37-44 g 
were used to evaluate food consumption. Mice are first acclimated to laboratory 
condition at 23 °C with a 12 hours light-dark cycle for 1 week. Mice were orally 
administrated with water, 2 mM EGCg solution, or 2 mM EC solution of 200 
μl/mouse just before a dark cycle at 8 o'clock PM, and were allowed ad libitum access 
to food (Japan SLC) and drinking water. The amount of food left in the individual 
cage was weighed at every two hours for 24 hours. Subtraction between the left food 
amounts was calculated to obtain food consumption in each 2 hours. Data were 
presented as means ± SEM of five mice. 
3.2.1 Evaluation of food intake 
 
3.2.2 
Statistical analysis was performed using Student’s t-test.
Statistical Analysis 
 
  
Probability values less 
than 0.05 were considered statistically significant.  
 
63 
 
3.3 Result 
The food consumption was measured in every 2 hours after administration of 
EGCg or water. As shown in Figure 3.1A, food consumption after 2 hours is 
significantly less in EGCg administrated mice compare to control. When the amount 
of food cumulated, there was no significant difference between the groups later than 4 
hours after administration. The result indicated that the effect of EGCg on food 
consumption was observed in 2 hours as a reduction of food intake.  
3.3.1 Alteration of food consumption by EGCg  
 
3.3.2 Epicatechin doesn’t induce reduction of food intake 
Epicatechin (EC) shares basic structure of EGCg but doesn’t induce 
anorexigenic gut hormones (Figure 1.8). EC was administrated in the same way to 
EGCg and evaluated the food consumption. As shown in Figure 3.2A, food 
consumption in each 2 hours after administration of EC showed no difference to 
control for 24 hours, while EGCg showed significant reduction in the first 2 hours. 
The cumulated food consumption also didn’t change by EC compare to control. EC 
did not induce secretion of anorexigenic hormones or reduction of food intake. This 
result suggests that anorexigenic hormone release by EGCg affect reduction of food 
intake. 
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Figure 3.1. Effect of EGCg on food consumption for 24 hours.  
The 24 hours records of food consumption of mice administrated 200 μl of water or EGCg (2 
mM). (A) Consumed food amount for every 2 hours was shown for EGCg dosed mice (■, 
solid line) and water dosed mice (●, break line).  (B) Cumulative food intake after 
administration was shown by 2 hours for EGCg dosed mice (gray bar) and water dosed mice 
(white bar). *Statistical significance was determined by and Student’s t-test at p < 0.05 vs. 
each control (n=5). 
 
 
65 
 
 
Figure 3.2. Effect of EGCg and EC on food consumption for 24 hours.  
The 24 hours records of food consumption of mice administrated 200 μl of water,  EGCg (2 
mM) or EC (2 mM). (A) Consumed food amount for every 2 hours was shown for EC dosed 
mice (▲, dotted line), EGCg dosed mice (■, solid line) an d water dosed mice (●, break line).   
(B) Cumulative food intake after administration was shown by 2 hours for EC dosed mice 
(black bar), EGCg dosed mice (gray bar) and water dosed mice (white bar).  *Statistical 
significance was determined by and Student’s t-test at p < 0.05 vs. each control (n=5). 
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3.4 Discussion 
Secretion dynamics of gut hormones 
The secreted GLP-1 is rapidly inactivated by DPP IV, which cleaves off the N-
terminal 2 amino acids of GLP-1 [116]. This degradation occurred very quickly, so 
that the half-life time of intact GLP-1 is estimated as less than 2 minutes. Thus, the 
effect of GLP-1 is expected to continue only during the secreted period and doesn’t 
last long. The hormones secreted in plasma have a peak time of concentration. 
Concentration of GLP-1 in plasma in the empty stomach state is generally between 
the 5-10 pmol/L, and increase rapidly to 15-50 pmol/L after eating a meal in human [4, 
117]. In human, concentration of CCK in plasma is below 1 pmol/L in hungry 
condition to increase 5-10 pmol/L in satiety condition; whereas concentration of PYY 
in plasma is about 10 pmol/L in hungry condition to increase 20-25 pmol/L [118, 119]. 
GLP-1 is elevated in 5-30 minutes after food intake, reaching peak around 40 min 
[120].  PYY is increased in 15-30 minutes and CCK is 10-30 minutes after food 
intake [121, 122]. A range of experiments administrating anorexigenic hormones 
showed that the effect on food intake reduction was exhibited in 2-4 hours after 
administration. The observation of the reduction of food consumption during the 
first 2 hours after administration of EGCg (Figure 3.1A) speculates a relationship 
between anorexigenic effect of EGCg and anorexigenic gut hormones. As well as the 
result obtained by administration of EC, which had no effect on anorexigenic gut 
hormones, CCK, GLP-1 and PYY release in vitro (Figure 1.8) and on reduction of 
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food intake in vivo (Figure 3.2), it is probable that EGCg affect regulation of feeding 
behavior via secretion of anorexigenic gut hormones, CCK, GLP-1, and PYY.  
Contribution of gut hormones on regulation of food intake and energy 
expenditure 
One should balance the energy expenditure and supplementation in both short 
term and long term. To keep a good balance for total body energy, feeding behavior 
should be regulated correctly. Hypothalamus is considered to control food intake, 
since the lesion of that area decisively alters animals’ feeding behavior [3]. The area 
is largely divided into two; ventromedial nucleus as the satiety center and lateral 
hypothalamus as the fasting center [123]. The area where the neurons directly receive 
signals is arcuate nucleus, located at the bottom of hypothalamus. The signals 
transmitted to this feeding center are hormones secreted from gastrointestinal tract 
and adipocytes [124]. Leptin, a hormone secreted from adipose tissue, is known as a 
long term satiety hormone. It is revealed that this gene responsible for obesity, 
especially related to feeding behavior by mediating energy consumption [125, 126]. 
On the other hand, the gut hormones, such as CCK, GLP-1 and PYY are known as a 
short term signal for satiation.  They convey direct postprandial satiety signals to 
hypothalamus at ARC region, which is known to control energy and glucose 
metabolism [123]. It is probable that the gut hormones tightly relate to energy control.  
Oral administration of EGCg for 0.4 μmol per mouse altered the food 
consumption in first 2 hours about half of that of control (Figure 3.1A). After 
reducing food consumption during the first 2 hours, the cumulated food consumption 
 
68 
 
at 4 hours after administration was recovered to the level of control (Figure 3.1B). 
This might mean a normal control of feeding behavior related to whole body energy 
balance including the information not only from gut hormones but also other signals 
such as leptin. There is a report showing the chronic effect on a range of biochemical 
markers by administration of EGCg for 7 days using Sparague Dawley rats [44]. Male 
rats orally given 15 mg of EGCg for 7 days exhibited reduction in food intake at 15% 
from control, though body weight showed no difference. The serum concentrations of 
hormones which correlate with food intake were shown by 30% reduction for leptin, 
but not insulin. The dosage of EGCg used in that report was ten times higher, and the 
alteration of food intake was demonstrated as a result of repeated treatment. The 
effect of reduction of food intake by single administration of EGCg in palatable dose 
provides a new function of EGCg. Further experiment such as evaluation of food 
consumption in EGCg receptor knock out mice would be needed to clarify the 
involvement of gut hormones in feeding control by EGCg.  
When male Sprague Dawley rats were injected intraperitoneally with green tea 
catechins, EC, EGC, ECg and EGCg (each 85 mg/kg body weight) for 7 days, their 
food intake decreased for 50–60% by EGCg, whereas EC, EGC and ECg did not 
show any effect [44].  
 
In this chapter, the effect of EGCg on food intake was investigated in vivo. The 
cumulated food consumption during after 2 hours of EGCg administration detected 
significantly less than control. The effect for reduction of food intake might due to the 
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anorexigenic hormones, CCK, GLP-1 and PYY secreted from intestine in response to 
EGCg. The amount of EGCg dosed to mice was practical when calculated to human. 
Accordingly, it is expected that about 2 cup of green tea will affect human to reduce 
appetite, which will be possible to help from excessive eating.  
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Conclusion 
 
This study demonstrated that some polyphenols induce secretion of 
anorexigenic gut hormones such as CCK, GLP-1 and PYY. These findings will 
provide a new perspective on polyphenols as endocrine inducers and on their potential 
function in appetite regulation, which in turn controls energy balance. 
In chapter 1, it was firstly proven that some polyphenols such as EGCg, GCg, 
GC, chlorogenic acid, and ferulic acid released anorexigenic gut hormones in vitro. 
Particularly, EGCg secreted all three hormones. In an ex vivo assay using murine 
intestines, EGCg also induced secretion of anorexigenic gut hormones. EGCg, the 
major flavonoid found in green tea, has been reported to have an effect in food intake 
reduction. These facts support the possibility that food intake reduction by EGCg is 
related in anorexigenic gut hormone release. 
In chapter 2, it was shown that intracellular Ca2+ concentrations were increased 
responding to EGCg in NCI-H716 cells. Among candidates of EGCg receptors, 
hTAS2R39 are expected to be the receptor of EGCg for release of GLP-1 from gene 
expression analysis. The 67LR antibody did not affect gut hormone secretion and the 
TRPA1 antagonist did not affect gut hormone secretion, so these receptors seemed to 
be unrelated to secretion of gut hormone by EGCg. Analysis to inhibit PLC activity 
which is estimated to be the downstream of GPCR also showed no effect on GLP-1 
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release, speculated other pathway between hTAS2R39 and elevation of Ca2+
In chapter 3, orally administration of EGCg to mice was performed to evaluate 
its effect on food intake. The food consumption during 2 hours after administration of 
EGCg was suppressed, and food intake 
 
concentration. 
during a short time in vivo. By contrast of 
administration of EC, which did not induce anorexigenic hormones, had no change in 
food consumption. These results suggest that food intake reduction by EGCg, may be 
related in anorexigenic
This study showed that EGCg can induce anorexigenic gut hormone, which in 
turn supports that EGCg might affect appetite via gut hormones. Anti-obesity effect of 
EGCg has shown to act after being absorbed into the body, however, the 
bioavailability of absorbed EGCg is very little since polyphenols is hard to be 
absorbed and released from body in short term [1, 23]. Here, gut hormone release by 
reception in intestinal tract does not require a process of absorption, so is expected to 
have high bioavailability of EGCg. The anti-obesity effect of EGCg via anorexigenic 
gut hormone release has not been shown. Thus, the whole study here proposes a novel 
biological function of EGCg. 
 gut hormone secretion.  
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